Grandfield & Dodd LLC cut its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.8% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 7,052 shares of the pharmacy operator’s stock after selling 60 shares during the period. Grandfield & Dodd LLC’s holdings in Walgreens Boots Alliance were worth $552,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Hudock Capital Group LLC lifted its stake in Walgreens Boots Alliance by 0.4% in the 1st quarter. Hudock Capital Group LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $108,000 after buying an additional 5 shares in the last quarter. Tarbox Group Inc. lifted its stake in Walgreens Boots Alliance by 288.3% in the 1st quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock valued at $113,000 after buying an additional 1,006 shares in the last quarter. Reilly Financial Advisors LLC lifted its stake in Walgreens Boots Alliance by 7.9% in the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after buying an additional 100 shares in the last quarter. Webster Bank N. A. lifted its stake in Walgreens Boots Alliance by 18.4% in the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock valued at $125,000 after buying an additional 235 shares in the last quarter. Finally, Orrstown Financial Services Inc. lifted its stake in Walgreens Boots Alliance by 14.1% in the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after buying an additional 213 shares in the last quarter. Hedge funds and other institutional investors own 60.16% of the company’s stock.

In related news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Tuesday, July 25th. The shares were sold at an average price of $79.79, for a total transaction of $218,305.44. Following the transaction, the director now owns 19,151 shares of the company’s stock, valued at $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 13.50% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “Grandfield & Dodd LLC Has $552,000 Stake in Walgreens Boots Alliance, Inc. (WBA)” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece of content on another site, it was illegally stolen and reposted in violation of U.S. and international copyright and trademark law. The legal version of this piece of content can be viewed at https://www.thecerbatgem.com/2017/09/20/grandfield-dodd-llc-has-552000-stake-in-walgreens-boots-alliance-inc-wba.html.

A number of brokerages recently weighed in on WBA. Royal Bank of Canada began coverage on shares of Walgreens Boots Alliance in a research note on Tuesday. They issued an “outperform” rating and a $96.00 price target on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research note on Saturday. BidaskClub lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Tuesday, September 12th. Zacks Investment Research lowered shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating in a research note on Wednesday, June 14th. Finally, Jefferies Group LLC reaffirmed a “buy” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Two analysts have rated the stock with a sell rating, three have given a hold rating and fifteen have given a buy rating to the company’s stock. Walgreens Boots Alliance has an average rating of “Buy” and an average target price of $92.06.

Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) opened at 81.21 on Wednesday. The stock’s 50 day moving average is $81.36 and its 200 day moving average is $81.86. The stock has a market cap of $86.90 billion, a price-to-earnings ratio of 20.51 and a beta of 1.26. Walgreens Boots Alliance, Inc. has a 52-week low of $75.18 and a 52-week high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings data on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.03. The business had revenue of $30.12 billion for the quarter, compared to the consensus estimate of $29.72 billion. Walgreens Boots Alliance had a net margin of 3.69% and a return on equity of 17.34%. The company’s quarterly revenue was up 2.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.18 earnings per share. On average, equities analysts expect that Walgreens Boots Alliance, Inc. will post $5.00 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 18th were paid a dividend of $0.40 per share. This is an increase from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 annualized dividend and a dividend yield of 1.97%. Walgreens Boots Alliance’s dividend payout ratio is presently 40.30%.

Walgreens Boots Alliance declared that its board has authorized a share buyback program on Thursday, June 29th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.